Repligen Market Cap

Repligen has a market cap or net worth of $9.37 billion as of January 8, 2026. Its market cap has increased by 14.10% in one year.

Market Cap

9.37B

Enterprise Value

9.31B

1-Year Change

14.10%

Ranking

#954

Market Cap Chart

Since December 1, 1998, Repligen's market cap has increased from $28.10M to $9.37B, an increase of 33,237.75%. That is a compound annual growth rate of 23.89%.

Market Cap History

Date	Market Cap	% Change
Jan 7, 2026	9.52B	3.17%
Dec 31, 2025	9.22B	14.38%
Dec 31, 2024	8.06B	-19.67%
Dec 29, 2023	10.04B	6.78%
Dec 30, 2022	9.40B	-35.80%
Dec 31, 2021	14.64B	45.21%
Dec 31, 2020	10.08B	109.40%
Dec 31, 2019	4.82B	108.18%
Dec 31, 2018	2.31B	46.35%
Dec 29, 2017	1.58B	51.58%
Dec 30, 2016	1.04B	11.88%
Dec 31, 2015	932.00M	43.85%
Dec 31, 2014	647.90M	48.87%
Dec 31, 2013	435.20M	122.72%
Dec 31, 2012	195.40M	83.30%
Dec 30, 2011	106.60M	-26.18%
Dec 31, 2010	144.40M	14.24%
Dec 31, 2009	126.40M	7.21%
Dec 31, 2008	117.90M	-41.78%
Dec 31, 2007	202.50M	137.12%
Dec 29, 2006	85.40M	-29.07%
Dec 30, 2005	120.40M	39.03%
Dec 31, 2004	86.60M	-33.64%
Dec 31, 2003	130.50M	57.04%
Dec 31, 2002	83.10M	28.04%

View and export this data all the way back to 1998. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Eli Lilly and Company	952.72B
Johnson & Johnson	493.40B
AbbVie	395.77B
UnitedHealth Group	316.11B
AstraZeneca	293.89B
Merck & Co.	270.22B
Novartis AG	268.87B
Novo Nordisk	253.02B

Market Cap Rankings